Annals of Laboratory Medicine

Korean Society for Laboratory Medicine (대한진단검사의학회)
권호 표지
DOI QR코드

DOI QR Code

False Homozygosity Results in HLA Genotyping due to Loss of Chromosome 6 in a Patient with Acute Lymphoblastic Leukemia

  • Park, Hye-Won (Department of Laboratory Medicine, Seoul National University College of Medicine) ;
  • Hyun, Jun-Won (Department of Laboratory Medicine, Seoul National University College of Medicine) ;
  • Park, Sung-Sup (Department of Laboratory Medicine, Seoul National University College of Medicine) ;
  • Park, Myoung-Hee (Department of Laboratory Medicine, Seoul National University College of Medicine) ;
  • Song, Eun-Young (Department of Laboratory Medicine, Seoul National University College of Medicine)
  • Published : 2011.10.30
⟨ Previous Next ⟩

Abstract

Loss of heterozygosity (LOH) in chromosome 6p has been reported in a number of tumors and some hematologic malignancies, including ALL. LOH in chromosome 6p, on which the HLA genes are located, can give rise to false homozygosity results in HLA genotyping of patients with hematologic malignancies. Here we report false homozygosity results in HLA genotyping due to the loss of whole chromosome 6 in the neoplastic cells of a patient with ALL. A 33-yr-old Korean female patient was admitted for the evaluation of leukocytosis detected during a workup for headache. Her initial white blood cell count was $336.9{\times}10^9$/L with 84% of blasts in the differential count. Precursor-B lymphoblastic leukemia was diagnosed from a subsequent bone marrow study. HLA high-resolution genotyping of the patient was requested at the time of diagnosis for possible hematopoietic stem cell transplantation. Homozygosity results (A*02:01, B*54:01, C*08:01, DQB1*04:01) were obtained, except for the DRB1 locus (DRB1*04:05, DRB1*11:01), in sequence-based typing. Conventional karyotyping of bone marrow metaphase cells revealed chromosomal abnormalities, with loss of multiple chromosomes including chromosome 6, and reduplication of the remaining chromosomes: 29,X,+X,+8,inv(9)(p11q13),+10,+14,+18,+21[15]/58,idemX2[3]/46,XX,inv(9)[2]. LOH at the HLA region was suspected and HLA genotyping was repeated with the peripheral blood in remission state after induction chemotherapy. All 5 HLA loci were typed as heterozygous (A*02:01, A*02:06, B*40:01, B*54:01, C*03:04, C*08:01, DRB1*04:05, DRB1*11:01, DQB1*03:01, DQB1*04:01). To avoid false HLA typing results in patients with hematologic malignancies, clinicians, as well as laboratory personnel, need to be aware of such problems and take appropriate precautions.

Keywords

References

  1. Garrido F, Cabrera T, Concha A, Glew S, Ruiz-Cabello F, Stern PL. Natural history of HLA expression during tumour development. Immunol Today 1993;14:491-9. https://doi.org/10.1016/0167-5699(93)90264-L
  2. Ferrone S and Marincola FM. Loss of HLA class I antigens by melanoma cells" molecular mechanisms, functional significance and clinical relevance. Immunol Today 1995;16:487-94. https://doi.org/10.1016/0167-5699(95)80033-6
  3. Garrido F, Ruiz-Cabello F, Cabrera T, Perez-Villar JJ, Lopez-Botet M, Duggan-Keen M, et al. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol Today. 1997;18:89-95. https://doi.org/10.1016/S0167-5699(96)10075-X
  4. Browning M, Petronzelli F, Bicknell D, Krausa P, Rowan A, Tonks S, et al. Mechanisms of loss of HLA class I expression on colorectal tumor cells. Tissue Antigens 1996;47:364-71. https://doi.org/10.1111/j.1399-0039.1996.tb02571.x
  5. D'Urso CM, Wang ZG, Cao Y, Tatake R, Zeff RA, Ferrone S. Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression. J Clin Invest 1991;87:284-92. https://doi.org/10.1172/JCI114984
  6. Spies T and DeMars R. Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter. Nature 1991;351:323-4. https://doi.org/10.1038/351323a0
  7. Browning MJ, Krausa P, Rowan A, Hill AB, Bicknell DC, Bodmer JG, et al. Loss of human leukocyte antigen expression on colorectal tumor cell lines: implications for anti-tumor immunity and immunotherapy. J Immunother Emphasis Tumor Immunol 1993;14: 163-8. https://doi.org/10.1097/00002371-199310000-00001
  8. Koopman LA, Mulder A, Corver WE, Anholts JD, Giphart MJ, Claas FH, et al. HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines. Tissue Antigens 1998; 51:623-36. https://doi.org/10.1111/j.1399-0039.1998.tb03005.x
  9. Torres MJ, Ruiz-Cabello F, Skoudy A, Berrozpe G, Jimenez P, Serrano A, et al. Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line. Tissue Antigens 1996; 47:372-81. https://doi.org/10.1111/j.1399-0039.1996.tb02572.x
  10. Soong TW and Hui KM. Locus-specific transcriptional control of HLA genes. J Immunol 1992;149:2008-20.
  11. Koopman LA, van Der Slik AR, Giphart MJ, Fleuren GJ. Human leukocyte antigen class I gene mutations in cervical cancer. J Natl Cancer Inst 1999;91:1669-77. https://doi.org/10.1093/jnci/91.19.1669
  12. Jimenez P, Canton J, Collado A, Cabrera T, Serrano A, Real LM, et al. Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors. Int J Cancer 1999;83: 91-7.
  13. McEvoy CR, Morley AA, Firgaira FA. Evidence for whole chromosome 6 loss and duplication of the remaining chromosome in acute lymphoblastic leukemia. Genes Chromosomes Cancer 2003;37: 321-5. https://doi.org/10.1002/gcc.10214
  14. Coppage M, Busacco A, Lenog N, Rothberg P, Phillips G, Becker M. Leukemia specific loss of heterozygosity at MHC locus detected at confirmatory typing of HSCT recipient with CLL. Hum Immunol 2010;71(S):S130.
  15. Maleno I, Lopez-Nevot MA, Cabrera T, Salinero J, Garrido F. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21. Cancer Immunol Immunother 2002;51:389-96. https://doi.org/10.1007/s00262-002-0296-0
  16. Masuda K, Hiraki A, Fujii N, Watanabe T, Tanaka M, Matsue K, et al. Loss or down-regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts. Cancer Sci 2007;98:102-8. https://doi.org/10.1111/j.1349-7006.2006.00356.x
  17. Baccichet A, Qualman SK, Sinnett D. Allelic loss in childhood acute lymphoblastic leukemia. Leuk Res 1997;21:817-23. https://doi.org/10.1016/S0145-2126(97)00075-1
  18. Takeuchi S, Bartram CR, Wada M, Reiter A, Hatta Y, Seriu T, et al. Allelotype analysis of childhood acute lymphoblastic leukemia. Cancer Res 1995;55:5377-82.
  19. Ljungman P, de Witte T, Verdonck L, Gahrton G, Freycon F, Gravett P, et al. Bone marrow transplantation for acute myeloblastic leukaemia: an EBMT Leukaemia Working Party prospective analysis from HLA-typing. Br J Haematol 1993;84:61-6. https://doi.org/10.1111/j.1365-2141.1993.tb03025.x
  20. European Federation for Immunogenetics (Eds), Standards for histocompatibility testing, version 5.6.1. http://www.efiweb.eu/index.php?id=102 (Updated on Oct 2009).
  21. Treleaven JG, Barrett AJ, eds. Hematopoietic stem cell transplantation in clinical practice. 1st ed. Churchill Livingstone, 2008:224.

Cited by

  1. Two cases of acute lymphoid leukemia patients with loss of heterozygosity in HLA region before transplantation vol.98, pp.3, 2011, https://doi.org/10.1111/tan.14372